These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6794374)

  • 21. Inflammatory process in acute gouty arthritis. 3. Vascular permeability-enhancing activity in normal human synovial fluid; induction by Hageman factor activators; and inhibition by Hageman factor antiserum.
    Kellermeyer RW
    J Lab Clin Med; 1967 Sep; 70(3):372-83. PubMed ID: 6038543
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of Hageman factor/kallikrein-kinin system in pseudomonal elastase-induced shock model.
    Khan MM; Yamamoto T; Araki H; Shibuya Y; Kambara T
    Biochim Biophys Acta; 1993 Jun; 1157(2):119-26. PubMed ID: 8507648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary structure of guinea-pig Hageman factor: sequence around the cleavage site differs from the human molecule.
    Semba U; Yamamoto T; Kunisada T; Shibuya Y; Tanase S; Kambara T; Okabe H
    Biochim Biophys Acta; 1992 Sep; 1159(2):113-21. PubMed ID: 1390917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.
    Matheson RT; Miller DR; Lacombe MJ; Han YN; Iwanaga S; Kato H; wuepper KD
    J Clin Invest; 1976 Dec; 58(6):1395-406. PubMed ID: 993350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.
    Senger DR; Perruzzi CA; Feder J; Dvorak HF
    Cancer Res; 1986 Nov; 46(11):5629-32. PubMed ID: 3756910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to guinea pig lymphokines. II. Suppression of delayed hypersensitivity reactions by a "second generation" goat antibody against guinea pig lymphokines.
    Geczy CL; Geczy AF; De Weck AL
    J Immunol; 1976 Jul; 117(1):66-72. PubMed ID: 1084371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary structure of bovine Hageman factor (blood coagulation factor XII): comparison with human and guinea pig molecules.
    Shibuya Y; Semba U; Okabe H; Kambara T; Yamamoto T
    Biochim Biophys Acta; 1994 May; 1206(1):63-70. PubMed ID: 8186251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A proteaselike permeability factor in guinea pig skin: contact activation of the latent permeability factor and its nature as a prekallikrein activator.
    Kozono K; Yamamoto T; Kambara T
    Am J Pathol; 1980 Sep; 100(3):619-32. PubMed ID: 6998297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins.
    Colman RW; Mattler L; Sherry S
    J Clin Invest; 1969 Jan; 48(1):11-22. PubMed ID: 4974623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular heterogeneity of Hageman trait (factor XII deficiency): evidence that two of 49 subjects are cross-reacting material positive (CRM+).
    Saito H; Scott JG; Movat HZ; Scialla SJ
    J Lab Clin Med; 1979 Aug; 94(2):256-65. PubMed ID: 110893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physicochemical characterization of a vascular permeability factor produced by con A-stimulated human lymphocytes.
    Sobel AT; Branellec AI; Blanc CJ; Lagrue GA
    J Immunol; 1977 Oct; 119(4):1230-4. PubMed ID: 894032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Promotion mechanism of vascular permeability by Hageman factor].
    Yamamoto T
    Rinsho Byori; 1982 Jun; Suppl 50():114-26. PubMed ID: 7131802
    [No Abstract]   [Full Text] [Related]  

  • 33. Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein.
    Cochrane CG; Revak SD; Wuepper KD
    J Exp Med; 1973 Dec; 138(6):1564-83. PubMed ID: 4271629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A protease-like permeability factor in the guinea pig skin. 1. Partial purification and characterization.
    Yamamoto T; Kambara T
    Biochim Biophys Acta; 1978 Apr; 540(1):55-64. PubMed ID: 25092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.
    Imamura T; Dubin A; Moore W; Tanaka R; Travis J
    Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation and structure of human Hageman factor fragments.
    Dunn JT; Kaplan AP
    J Clin Invest; 1982 Sep; 70(3):627-31. PubMed ID: 6921203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contact-activated factors: contaminants of immunoglobulins preparations with coagulant and vasoactive properties.
    Alving BM; Tankersley DL; Mason BL; Rossi F; Aronson DL; Finlayson JS
    J Lab Clin Med; 1980 Aug; 96(2):334-46. PubMed ID: 6447181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between PF-DIL and activated human Hageman factor.
    Johnston AR; Cochrane CG; Revak SD
    J Immunol; 1974 Jul; 113(1):103-9. PubMed ID: 4208914
    [No Abstract]   [Full Text] [Related]  

  • 39. Vascular permeability enhancement by Vibrio mimicus protease and the mechanisms of action.
    Chowdhury MA; Miyoshi S; Shinoda S
    Microbiol Immunol; 1991; 35(12):1049-58. PubMed ID: 1808459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hageman factor-dependent kinin activation in burns and its theoretical relationship to postburn immunosuppression syndrome and infection.
    Holder IA; Neely AN
    J Burn Care Rehabil; 1990; 11(6):496-503. PubMed ID: 2286602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.